A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage

M. Lederhandler*, L. Chen, S. A. Meehan, N. K. Brinster, A. Neimann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Porphyria cutanea tarda (PCT) is the most common type of porphyria, presenting in middle-aged patients with a photodistributed vesiculobullous eruption, milia, and scars. Porphyria cutanea tarda occurs in relation to inhibition of uroporphyrinogen decarboxylase, a key enzyme in the heme biosynthesis pathway. A number of genetic and acquired factors increase susceptibility to PCT by reducing uroporphyrinogen decarboxylase activity. A handful of other vesiculobullous conditions may mimic PCT both clinically and histologically; therefore, both skin biopsy and laboratory evaluation are helpful in confirming the diagnosis. We report a case of PCT in the setting of cigarette usage and untreated hepatitis C infection.

Original languageEnglish (US)
Article number11
JournalDermatology online journal
Volume25
Issue number12
StatePublished - Dec 2019

Keywords

  • Hepatitis C
  • Porphyria cutanea tarda
  • Tobacco
  • Treatment

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage'. Together they form a unique fingerprint.

Cite this